Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.

Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.

Cancer Res. 2006 Jan 15;66(2):867-74.

PMID:
16424019
[PubMed - indexed for MEDLINE]
Free Article
2.

The EGFRvIII variant in glioblastoma multiforme.

Gan HK, Kaye AH, Luwor RB.

J Clin Neurosci. 2009 Jun;16(6):748-54. doi: 10.1016/j.jocn.2008.12.005. Epub 2009 Mar 25. Review.

PMID:
19324552
[PubMed - indexed for MEDLINE]
3.

Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications.

Nagane M, Lin H, Cavenee WK, Huang HJ.

Cancer Lett. 2001 Jan;162 Suppl:S17-S21. Review.

PMID:
11164186
[PubMed - indexed for MEDLINE]
4.

Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.

Karpel-Massler G, Wirtz CR, Halatsch ME.

Molecules. 2010 Jun 30;15(7):4670-8. doi: 10.3390/molecules15074670. Review.

PMID:
20657384
[PubMed - indexed for MEDLINE]
Free Article
5.

Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.

Hatanpaa KJ, Burma S, Zhao D, Habib AA.

Neoplasia. 2010 Sep;12(9):675-84. Review.

PMID:
20824044
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.

Kopp R, Rothbauer E, Ruge M, Arnholdt H, Spranger J, Muders M, Pfeiffer DG, Schildberg FW, Pfeiffer A.

Recent Results Cancer Res. 2003;162:115-32. Review.

PMID:
12790326
[PubMed - indexed for MEDLINE]
7.

Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

Mimeault M, Batra SK.

Brain Pathol. 2011 Sep;21(5):479-500. doi: 10.1111/j.1750-3639.2011.00505.x. Epub 2011 Jul 7. Review.

PMID:
21615592
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mutant epidermal growth factor receptors as targets for cancer therapy.

Lorimer IA.

Curr Cancer Drug Targets. 2002 Jun;2(2):91-102. Review.

PMID:
12188912
[PubMed - indexed for MEDLINE]
9.

Sequential changes in epidermal growth factor receptor/ligand function in cultured rat liver epithelial cells transformed chemically in vitro.

Grisham JW, Tsao MS, Lee DC, Earp HS.

Pathobiology. 1990;58(1):3-14. Review.

PMID:
2187476
[PubMed - indexed for MEDLINE]
10.

Oncogenes: cause or consequence in the development of glial tumors.

Akbasak A, Sunar-Akbasak B.

J Neurol Sci. 1992 Sep;111(2):119-33. Review.

PMID:
1331337
[PubMed - indexed for MEDLINE]
11.

The autocrine loop of TGF-alpha/EGFR and brain tumors.

Tang P, Steck PA, Yung WK.

J Neurooncol. 1997 Dec;35(3):303-14. Review.

PMID:
9440027
[PubMed - indexed for MEDLINE]
12.

Targeting ErbB receptors in high-grade glioma.

Berezowska S, Schlegel J.

Curr Pharm Des. 2011;17(23):2468-87. Review.

PMID:
21827413
[PubMed - indexed for MEDLINE]
13.

EGFRvIII as a promising target for antibody-based brain tumor therapy.

Kuan CT, Wikstrand CJ, Bigner DD.

Brain Tumor Pathol. 2000;17(2):71-8. Review.

PMID:
11210174
[PubMed - indexed for MEDLINE]
14.

EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

Lo HW, Hsu SC, Hung MC.

Breast Cancer Res Treat. 2006 Feb;95(3):211-8. Review.

PMID:
16261406
[PubMed - indexed for MEDLINE]
15.

Growth factor receptors and their ligands.

Eppenberger U, Mueller H.

J Neurooncol. 1994;22(3):249-54. Review.

PMID:
7760103
[PubMed - indexed for MEDLINE]
16.

Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm.

Boerner JL, Danielsen A, Maihle NJ.

Exp Cell Res. 2003 Mar 10;284(1):111-21. Review.

PMID:
12648470
[PubMed - indexed for MEDLINE]
17.

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.

Gan HK, Cvrljevic AN, Johns TG.

FEBS J. 2013 Nov;280(21):5350-70. doi: 10.1111/febs.12393. Epub 2013 Jul 8. Review.

PMID:
23777544
[PubMed - indexed for MEDLINE]
18.

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy.

Pedersen MW, Meltorn M, Damstrup L, Poulsen HS.

Ann Oncol. 2001 Jun;12(6):745-60. Review.

PMID:
11484948
[PubMed - indexed for MEDLINE]
Free Article
19.

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

Chakravarti A, Dicker A, Mehta M.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):927-31. Review.

PMID:
14967452
[PubMed - indexed for MEDLINE]
20.

Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas.

Nathoo N, Goldlust S, Vogelbaum MA.

Neurosurgery. 2004 Jun;54(6):1480-8; discussion 1488-9. Review.

PMID:
15157306
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk